Table 2 Number and percent of channel catfish (Ictalurus punctatus) 4-month-old fingerlings with congenital anomalies due to microinjection of three different dosages of gRNAs/Cas9 protein targeting toll/interleukin 1 receptor domain-containing adapter molecule (TICAM 1) gene and rhamnose binding lectin (RBL) gene.

From: Effects of CRISPR/Cas9 dosage on TICAM1 and RBL gene mutation rate, embryonic development, hatchability and fry survival in channel catfish

Gene

Dosage

Number and percent of fingerlings with anomaly*

Total number

Absence of eye development

Absence of barbel

Deformed head

Spinal deformity

TICAM1

Low

0 (0%)

0 (0%)

0 (0%)

0 (0%)

50

Medium

0 (0%)

0 (0%)

2 (15.4%)

0 (0%)

13

High

0 (0%)

1 (6.3%)

3 (18.8%) (two were mutated, one was not)

0 (0%)

16

RBL

Low

2 (7.7%)

0 (0%)

1 (3.8%)

1 (3.8%)

26

Medium

1 (10%)

0 (0%)

0 (0%)

0 (0%)

10

High

1 (7.7%)

0 (0%)

0 (0%)

0 (0%)

13

  1. Three dosages for each gene were injected including low dosage: 2.5 ng gRNA/7.5 ng Cas9 protein, medium dosage: 5 ng gRNA/15 ng Cas9 protein and high dosage: 7.5 ng gRNA/22.5 ng Cas9 protein. All injected and non-injected 4-month-old control fry were free of any anomalies (see Fig. 3).
  2. *All fingerlings with anomalies were mutated except one from the TICAM 1 high dosage that had head deformity but was not mutated.